Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
17 results
D2.475 - Treatment delay and likelihood of remission on omalizumab in chronic spontaneous urticaria: a real-world observational study
D2.465 - Omalizumab Enhances Safety and Supports Completion of Oral Immunotherapy in High-Risk Patients
D2.466 - More options for the treatment of Chronic Spontaneous Urticaria: Tezepelumab
D2.467 - Management of Netherton syndrome and hereditary angioedema with concurrent biologic therapy: a novel case
D2.468 - Real-world effectiveness and safety of dupilumab in pediatric atopic dermatitis: a retrospective cohort study
D2.469 - Pre-switch perceptions of omalizumab biosimilar prefilled pen in pediatric allergy: a cross-sectional survey
D2.472 - Immunology Innovation Program: Developing Antibodies Against Novel Targets Through Co-creation
D2.474 - Use of Dupilumab as treatment for Eosinophilic Enteritis: a case report
D2.476 - Mepolizumab Enables Meaningful Real-World Improvements in SNOT-22 and Smell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps: Post Hoc Analysis of REALITI-N at 3 and 6 Months
D3.485 - Prevalence of Ambrosia artemisiifolia in Italy: Bioinformatics and Botanical Aerobiology Analysis
D3.478 - Microsplenia: Spleen Size Reduction as a Comprehensive Biomarker for Immune-Related Diseases, Disease Monitoring, and Treatment Response
D3.479 - Association between Mitochondrial DNA Copy Number and Lung Function in Schoolchildren
D3.481 - Machine Learning–Based Plasma Proteomic Signatures for Prediction of Chronic Rhinosinusitis
D3.482 - Harnessing the Baseline Nasal Microbiome to Predict Pollen Related Symptom Expression
D3.483 - Wearable Energy-efficient Device development for Real-time Evaluation, Analysis, and Monitoring platform
D3.486 - Acute hepatitis B with atypical serological markers in a previously vaccinated patient receiving anti-CD20 obinutuzumab
D3.487 - Intersection of Micronutrient Malabsorption Symptoms and Iron Deficiency in a Diet interaction in East African Population
Download the app
The congress at your fingertips
Available on
Download